Brett Kaplan - Chief Operating Officer at Eliem Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Stock Symbol
ELYM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Brett Kaplan since 11/5/2023

Holdings reported by Brett Kaplan for Eliem Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 77.5K $618K $7.98 Aug 26, 2024 Direct Common Stock
Stock Option (Right to Buy) 465K Aug 26, 2024 Direct Common Stock

Transactions reported by Brett Kaplan for Eliem Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.